Trial Profile
A Randomized, Open-label, Oral Multiple Dosing, Two-way Crossover Clinical Trial to Evaluate the Safety/Tolerability and Pharmacokinetic Profiles of SID142 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Feb 2019
Price :
$35
*
At a glance
- Drugs Cilostazol/ginkgo biloba (Primary) ; Cilostazol/ginkgo biloba (Primary)
- Indications Arterial occlusive disorders
- Focus Pharmacokinetics
- Sponsors SK Chemicals
- 11 Dec 2015 New trial record